Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer von Baca, Sylvan C., Takeda, David Y., Seo, Ji-Heui, Hwang, Justin, Ku, Sheng Yu, Arafeh, Rand, Arnoff, Taylor, Agarwal, Supreet, Bell, Connor, O’Connor, Edward, Qiu, Xintao, Alaiwi, Sarah Abou, Corona, Rosario I., Fonseca, Marcos A. S., Giambartolomei, Claudia, Cejas, Paloma, Lim, Klothilda, He, Monica, Sheahan, Anjali, Nassar, Amin, Berchuck, Jacob E., Brown, Lisha, Nguyen, Holly M., Coleman, Ilsa M., Kaipainen, Arja, De Sarkar, Navonil, Nelson, Peter S., Morrissey, Colm, Korthauer, Keegan, Pomerantz, Mark M., Ellis, Leigh, Pasaniuc, Bogdan, Lawrenson, Kate, Kelly, Kathleen, Zoubeidi, Amina, Hahn, William C., Beltran, Himisha, Long, Henry W., Brown, Myles, Corey, Eva, Freedman, Matthew L.

Volltext

PIK3CA in cancer: The past 30 years von Arafeh, Rand, Samuels, Yardena

Volltext

Harnessing synthetic lethality to predict the response to cancer treatment von Lee, Joo Sang, Das, Avinash, Jerby-Arnon, Livnat, Arafeh, Rand, Auslander, Noam, Davidson, Matthew, McGarry, Lynn, James, Daniel, Amzallag, Arnaud, Park, Seung Gu, Cheng, Kuoyuan, Robinson, Welles, Atias, Dikla, Stossel, Chani, Buzhor, Ella, Stein, Gidi, Waterfall, Joshua J., Meltzer, Paul S., Golan, Talia, Hannenhalli, Sridhar, Gottlieb, Eyal, Benes, Cyril H., Samuels, Yardena, Shanks, Emma, Ruppin, Eytan

Volltext

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies von Hwang, Justin H, Arafeh, Rand, Seo, Ji-Heui, Baca, Sylvan C, Ludwig, Megan, Arnoff, Taylor E, Sawyer, Lydia, Richter, Camden, Tape, Sydney, Bergom, Hannah E, McSweeney, Sean, Rennhack, Jonathan P, Klingenberg, Sarah A, Cheung, Alexander T M, Kwon, Jason, So, Jonathan, Kregel, Steven, Van Allen, Eliezer M, Drake, Justin M, Freedman, Matthew L, Hahn, William C

Volltext

Recurrent inactivating RASA2 mutations in melanoma von Arafeh, Rand, Qutob, Nouar, Emmanuel, Rafi, Keren-Paz, Alona, Madore, Jason, Elkahloun, Abdel, Wilmott, James S, Gartner, Jared J, Di Pizio, Antonella, Winograd-Katz, Sabina, Sindiri, Sivasish, Rotkopf, Ron, Dutton-Regester, Ken, Johansson, Peter, Pritchard, Antonia L, Waddell, Nicola, Hill, Victoria K, Lin, Jimmy C, Hevroni, Yael, Rosenberg, Steven A, Khan, Javed, Ben-Dor, Shifra, Niv, Masha Y, Ulitsky, Igor, Mann, Graham J, Scolyer, Richard A, Hayward, Nicholas K, Samuels, Yardena

Volltext

Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells von Arafeh, Rand, Flores, Karen, Keren-Paz, Alona, Maik-Rachline, Galia, Gutkind, Naomi, Rosenberg, Steven, Seger, Rony, Samuels, Yardena

Volltext

Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells von Arafeh, Rand, Flores, Karen, Keren-Paz, Alona, Maik-Rachline, Galia, Gutkind, Naomi, Rosenberg, Steven, Seger, Rony, Samuels, Yardena

Volltext

NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membrane von Yakovian, Oren, Sajman, Julia, Alon, Michal, Arafeh, Rand, Samuels, Yardena, Sherman, Eilon

Volltext

Biologically informed deep neural network for prostate cancer discovery von Elmarakeby, Haitham A., Hwang, Justin, Arafeh, Rand, Crowdis, Jett, Gang, Sydney, Liu, David, AlDubayan, Saud H., Salari, Keyan, Kregel, Steven, Richter, Camden, Arnoff, Taylor E., Park, Jihye, Hahn, William C., Van Allen, Eliezer M.

Volltext

The present and future of the Cancer Dependency Map von Arafeh, Rand, Shibue, Tsukasa, Dempster, Joshua M, Hahn, William C, Vazquez, Francisca

Volltext

MEK Inhibition Reverses Aberrant Signaling in Melanoma Cells through Reorganization of NRas and BRAF in Self Nanoclusters von Yakovian, Oren, Sajman, Julia, Arafeh, Rand, Neve-Oz, Yair, Alon, Michal, Samuels, Yardena, Sherman, Eilon

Volltext

Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer von Hagel, Kimberly R, Arafeh, Rand, Gang, Sydney, Arnoff, Taylor E, Larson, Rebecca C, Doench, John G, Mathewson, Nathan D, Wucherpfennig, Kai W, Maus, Marcela V, Hahn, William C

Volltext

A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS‐mutant melanoma von Nagler, Adi, Vredevoogd, David W., Alon, Michal, Cheng, Phil F., Trabish, Sophie, Kalaora, Shelly, Arafeh, Rand, Goldin, Victoria, Levesque, Mitchell P., Peeper, Daniel S., Samuels, Yardena

Volltext

Biologically Informed Deep Neural Network for Prostate Cancer Discovery von Elmarakeby, Haitham A, Hwang, Justin, Arafeh, Rand, Crowdis, Jett, Gang, Sydney, Liu, David, AlDubayan, Saud H, Salari, Keyan, Kregel, Steven, Richter, Camden, Arnoff, Taylor E, Park, Jihye, Hahn, William, Van Allen, Eliezer

Volltext

RASA2 and NF1; two-negative regulators of Ras with complementary functions in melanoma von Arafeh, Rand, Di Pizio, Antonella, Elkahloun, Abdel G., Dym, Orly, Niv, Masha Y., Samuels, Yardena

Volltext

miR-27a and miR-27a contribute to metastatic properties of osteosarcoma cells von Salah, Zaidoun, Arafeh, Rand, Maximov, Vadim, Galasso, Marco, Khawaled, Saleh, Abou-Sharieha, Samah, Volinia, Stefano, Jones, Kevin B, Croce, Carlo M, Aqeilan, Rami I

Volltext

CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma von Alon, Michal, Arafeh, Rand, Lee, Joo Sang, Madan, Sanna, Kalaora, Shelly, Nagler, Adi, Abgarian, Tereza, Greenberg, Polina, Ruppin, Eytan, Samuels, Yardena

Volltext

Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma von Alon, Michal, Arafeh, Rand, Lee, Joo Sang, Madan, Sanna, Kalaora, Shelly, Nagler, Adi, Abgarian, Tereza, Greenberg, Polina, Ruppin, Eytan, Samuels, Yardena

Volltext

Abstract A188: Harnessing synthetic lethality to predict the response to cancer treatments von Lee, Joo S., Das, Avinash, Jerby-Arnon, Livnat, Arafeh, Rand, Davidson, Matthew, Amzallag, Arnaud, Park, Seung Gu, Cheng, Kuoyuan, Robinson, Welles, Atias, Dikla, Stossel, Chani, Buzhor, Ella, Stein, Gidi, Waterfall, Joshua J., Meltzer, Paul S., Golan, Talia, Hannenhalli, Sridhar, Gottlieb, Eyal, Benes, Cyril H., Samuels, Yardena, Shanks, Emma, Ruppin, Eytan

Volltext

Abstract LB-031: Deciphering distinct roles of RASA2 in melanomagenesis von Arafeh, Rand, Qutob, Nouar, Emmanuel, Rafi Rafi, Madore, Jason, Elkahloun, Abdel, Wilmott, James S. James S., Gartner, Jared J., Pizio, Antonella Di, Rotkopf, Ron, Dutton-Regester, Ken, Hill, Victoria, Pritchard, Antonia, Lin, Jimmy C., Rosenberg, Steven A, Khan, Javed, Ben-Dor, Shifra, Niv, Masha Y. Masha Y., Ulitsky, Igor, Mann, Graham J, Scolyer, Richard A., Hayward, Nicholas K., Samuels, Yardena

Volltext